SCNX (Scienture Holdings, Inc. Common Stock) Stock Analysis - SEC Filings

Scienture Holdings, Inc. Common Stock (SCNX) is a publicly traded Healthcare sector company. As of May 21, 2026, SCNX trades at $0.39 with a market cap of $15.99M and a P/E ratio of -0.14. SCNX moved -2.15% today. Year to date, SCNX is -25.14%; over the trailing twelve months it is -57.40%. Its 52-week range spans $0.24 to $9.55. Analyst consensus is buy with an average price target of $1.50. Rallies surfaces SCNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find SCNX SEC filings?

Rallies organizes SCNX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

SCNX Key Metrics

Key financial metrics for SCNX
MetricValue
Price$0.39
Market Cap$15.99M
P/E Ratio-0.14
EPS$-2.70
Dividend Yield0.00%
52-Week High$9.55
52-Week Low$0.24
Volume7.75K
Avg Volume0
Revenue (TTM)$431.61K
Net Income$-41.51M
Gross Margin76.80%

Latest SCNX News

SCNX Analyst Consensus

1 analysts cover SCNX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.50.

Common questions about SCNX

Where can I find SCNX SEC filings?
Rallies organizes SCNX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show SCNX 10-K and 10-Q filings?
Rallies organizes SCNX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is SCNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SCNX. It does not provide personalized investment advice.
SCNX

SCNX